Subject Author Posted Rep. last R. [desc] Views
Pin 2012-01-10 05:05 5 2012-02-07 11:11 19,596
Helmut 2012-01-06 01:47 9 2012-01-31 02:12 8,726
stdev 2012-01-11 19:01 3 2012-01-12 23:23 4,727
Helmut 2011-12-19 20:41 3 2012-01-05 16:55 10,670
yicaoting 2011-11-08 14:40 9 2011-11-12 06:05 12,591
yicaoting 2011-11-06 13:03 13 2011-11-06 17:29 12,854
Priyanka_kocheta 2009-12-03 12:12 11 2011-11-02 20:46 9,730
venkata krishna 2011-10-23 06:55 2 2011-10-30 05:15 3,503
yicaoting 2011-10-07 18:27 6 2011-10-08 14:02 8,431
madhavaraob 2010-03-05 12:42 2 2011-09-16 08:29 9,224
ElMag 2011-02-15 14:58 2 2011-02-24 10:16 5,401
balakotu 2011-01-17 08:43 0   2,334
ioanam 2010-11-23 13:48 7 2010-11-23 15:11 5,814
Dr. Harish L. Rao 2009-09-10 07:53 13 2010-10-21 16:47 19,374
kram 2010-10-19 08:16 1 2010-10-19 15:43 5,631
UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,671 registered users;
30 visitors (0 registered, 30 guests [including 5 identified bots]).
Forum time: 08:22 CEST (Europe/Vienna)

The difference between a surrogate and a true endpoint
is like the difference between a cheque and cash.
You can get the cheque earlier but then,
of course, it might bounce.    Stephen Senn

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5